Sports
Asian Games Hangzhou 2022 – The ITA notifies basketball player … – International Testing Agency
Reveal
Search
Menu
12 October 2023
The International Testing Agency (ITA), mandated by the Olympic Council of Asia (OCA) to independently handle areas of the anti-doping program at the Asian Games Hangzhou 2022, including results management, reports that a sample collected from basketball player Sami Bzai from Jordan has returned an Adverse Analytical Finding¹ for dehydrochloromethyl-testosterone metabolite, a non-specified Prohibited Substance, according to the Prohibited List of the World Anti-Doping Agency (WADA).
The sample was collected by the ITA at the Asian Games Hangzhou 2022 during an in-competition anti-doping control performed on 7 October 2023. The Sample Collection Authority was the China Anti-Doping Agency.
The athlete has been informed of the case. He has the right to request the analysis of the B-samples.
The matter will thereafter be referred to the Anti-Doping Division of the Court of Arbitration for Sport (CAS ADD) for adjudication under the OCA Anti-Doping Rules.
Given that the case is underway, there will be no further comments during the ongoing proceeding.
List of Anti-Doping Rule Violations at the Asian Games Hangzhou 2022
Contact Details
Avenue de Rhodanie 40B,
1007 Lausanne, Switzerland
[email protected]
The information contained in this website is for general information purposes only. The information is provided by ITA and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
We use cookies on our website to personalize content, to analyze traffic on our website to provide social media features. We share your data with our analytics partners and social media content providers. Find out more
The privacy policy can be accessed here
Your current state: Consent rejected.